Virus Caseload Surges, but So Does the Stock Market
Despite the US seeing a record 1 million cases Monday, the S&P 500 keeps powering upward.
The biotech firm says its booster shot gives good protection against Omicron.
Exceeding 6% returns over the next decade will likely require excess risk or consistently performing well above average.
Commodities are starting to drop in price and new supply will ease housing costs, argues economist David Rosenberg.
The lawsuit claims the fitness company and its executives lied about the prospects of post-COVID growth.